Suzanne Ildstad
Geen lopende functies
Vermogen: 12 M $ op 31-03-2024
Profiel
Suzanne T.
Ildstad is the founder of Talaris Therapeutics, Inc. which was founded in 2002.
She held the title of Chief Scientific Officer & Director from 2018 to 2022.
Dr. Ildstad is also the founder of the University of Louisville.
She received her undergraduate degree from the University of Minnesota.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
1.98% | 14-06-2023 | 507 980 ( 1.98% ) | 12 M $ | 31-03-2024 |
Eerdere bekende functies van Suzanne Ildstad
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Louisville | Founder | - |
| TOURMALINE BIO, INC. | Chief Executive Officer | 01-11-2018 |
Opleiding van Suzanne Ildstad
| University of Minnesota | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
